BofA/Merrill Lynch initiates coverage on Globus Medical (NYSE: GMED) with a Buy rating. PT $17.00.Shares of Globus Medical closed at $15.05 yesterday, with a 52 week range of $13.06-$15.79.
UBS downgraded GlaxoSmithKline (NYSE: GSK) from Buy to Neutral.Shares of GlaxoSmithKline closed at $46.49 yesterday, with a 52 week range of $39.92-$47.48.
BofA/Merrill Lynch downgraded Amphenol (NYSE: APH) from Buy to Neutral.Shares of Amphenol closed at $61.63 yesterday, with a 52 week range of $38.98-$62.82.
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com